Assessment of elderly fragility in outpatient chemotherapy treatment

Aim: to characterize and verify the fragility of the elderly in outpatient chemotherapy treatment in a university hospital of southern Brazil, and to identify the association between fragility and the following variables: chemotherapeutic effect, treatment time and selfreported diseases. Method: cro...

Full description

Bibliographic Details
Main Authors: Josiane Caroline Zimmermann, Margrid Beuter, Jamile Lais Bruinsma, Ana Cristina Geiss Casarolli, Caren da Silva Jacobi, Larissa Venturini
Format: Article
Language:Portuguese
Published: Universidade Federal de Santa Maria 2017-09-01
Series:Revista de Enfermagem da Universidade Federal de Santa Maria
Subjects:
Online Access:https://periodicos.ufsm.br/reufsm/article/view/24587
_version_ 1811336912390062080
author Josiane Caroline Zimmermann
Margrid Beuter
Jamile Lais Bruinsma
Ana Cristina Geiss Casarolli
Caren da Silva Jacobi
Larissa Venturini
author_facet Josiane Caroline Zimmermann
Margrid Beuter
Jamile Lais Bruinsma
Ana Cristina Geiss Casarolli
Caren da Silva Jacobi
Larissa Venturini
author_sort Josiane Caroline Zimmermann
collection DOAJ
description Aim: to characterize and verify the fragility of the elderly in outpatient chemotherapy treatment in a university hospital of southern Brazil, and to identify the association between fragility and the following variables: chemotherapeutic effect, treatment time and selfreported diseases. Method: cross-sectional study conducted with 70 elderly in the chemotherapy outpatient, from August to September 2014 by means of Edmonton Frail Scale and characterization form. Results: fifty percent did not present fragility, 31.4% were apparently vulnerable and 18.6% had some level of fragility. Among the frail elderly, 15.7% had mild fragility, 1.4% moderate and 1.4% severe. The association between frailty and self-reported diseases, time of treatment and chemotherapeutic effects was not statistically significant. Conclusion: it was point to applicability of the scale to identify predisposing factors for the fragility syndrome and to enable preventive actions for the elderly in chemotherapeutic treatment
first_indexed 2024-04-13T17:46:27Z
format Article
id doaj.art-d40b8429171e4569a9e244166012a1cd
institution Directory Open Access Journal
issn 2179-7692
2179-7692
language Portuguese
last_indexed 2024-04-13T17:46:27Z
publishDate 2017-09-01
publisher Universidade Federal de Santa Maria
record_format Article
series Revista de Enfermagem da Universidade Federal de Santa Maria
spelling doaj.art-d40b8429171e4569a9e244166012a1cd2022-12-22T02:36:56ZporUniversidade Federal de Santa MariaRevista de Enfermagem da Universidade Federal de Santa Maria2179-76922179-76922017-09-017229130310.5902/217976922458713563Assessment of elderly fragility in outpatient chemotherapy treatmentJosiane Caroline Zimmermann0Margrid Beuter1Jamile Lais Bruinsma2Ana Cristina Geiss Casarolli3Caren da Silva Jacobi4Larissa Venturini5Universidade Federal de Santa Maria, Santa Maria, RSUniversidade Federal de Santa Maria, Santa Maria, RSUniversidade Federal de Santa Maria, Santa Maria, RSUniversidade Federal de Santa Maria, Santa Maria, RSUniversidade Federal de Santa Maria, Santa Maria, RSUniversidade Federal de Santa Maria, Santa Maria, RSAim: to characterize and verify the fragility of the elderly in outpatient chemotherapy treatment in a university hospital of southern Brazil, and to identify the association between fragility and the following variables: chemotherapeutic effect, treatment time and selfreported diseases. Method: cross-sectional study conducted with 70 elderly in the chemotherapy outpatient, from August to September 2014 by means of Edmonton Frail Scale and characterization form. Results: fifty percent did not present fragility, 31.4% were apparently vulnerable and 18.6% had some level of fragility. Among the frail elderly, 15.7% had mild fragility, 1.4% moderate and 1.4% severe. The association between frailty and self-reported diseases, time of treatment and chemotherapeutic effects was not statistically significant. Conclusion: it was point to applicability of the scale to identify predisposing factors for the fragility syndrome and to enable preventive actions for the elderly in chemotherapeutic treatmenthttps://periodicos.ufsm.br/reufsm/article/view/24587envelhecimentoidoso fragilizadoneoplasiasenfermagemquimioterapia
spellingShingle Josiane Caroline Zimmermann
Margrid Beuter
Jamile Lais Bruinsma
Ana Cristina Geiss Casarolli
Caren da Silva Jacobi
Larissa Venturini
Assessment of elderly fragility in outpatient chemotherapy treatment
Revista de Enfermagem da Universidade Federal de Santa Maria
envelhecimento
idoso fragilizado
neoplasias
enfermagem
quimioterapia
title Assessment of elderly fragility in outpatient chemotherapy treatment
title_full Assessment of elderly fragility in outpatient chemotherapy treatment
title_fullStr Assessment of elderly fragility in outpatient chemotherapy treatment
title_full_unstemmed Assessment of elderly fragility in outpatient chemotherapy treatment
title_short Assessment of elderly fragility in outpatient chemotherapy treatment
title_sort assessment of elderly fragility in outpatient chemotherapy treatment
topic envelhecimento
idoso fragilizado
neoplasias
enfermagem
quimioterapia
url https://periodicos.ufsm.br/reufsm/article/view/24587
work_keys_str_mv AT josianecarolinezimmermann assessmentofelderlyfragilityinoutpatientchemotherapytreatment
AT margridbeuter assessmentofelderlyfragilityinoutpatientchemotherapytreatment
AT jamilelaisbruinsma assessmentofelderlyfragilityinoutpatientchemotherapytreatment
AT anacristinageisscasarolli assessmentofelderlyfragilityinoutpatientchemotherapytreatment
AT carendasilvajacobi assessmentofelderlyfragilityinoutpatientchemotherapytreatment
AT larissaventurini assessmentofelderlyfragilityinoutpatientchemotherapytreatment